[Treatment of glaucoma with beta receptor blockers].
We report the possibility of treatment with beta-adrenergic blocking agents in glaucoma-therapy. In open-angle glaucoma the therapy with beta-adrenergic blocking agents is often the best one. The combination of beta-adrenergic blocking agents with miotics is the therapy of choice in the treatment of closure-angle glaucoma. In special forms of glaucoma it is necessary to decide if the best therapy is the treatment with beta-adrenergaic blocking agents alone or a combined treatment of beta-adrenergic blocking agents with miotics. The beta-adrenergic blocking agent timolol (Chibro-Timoptol) and bupranolol (Ophtorenin) lower in the intraocular pressure to a greater extent than other beta-adrenergic blocking agents. Timolol eye drops and bupranolol eye drops are therefore the best beta-adrenergic blocking agents in therpay of glaucoma.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001667:Binding, Competitive; D002046:Bupranolol / Q000627:therapeutic use; D004347:Drug Interactions; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D013999:Timolol; D002046:Bupranolol
Glaukom-Behandlung mit Beta-Rezeptorenblockern.